Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

Market Cap	55.41B -14.3%
Revenue (ttm)	280.69B +3.0%
Net Income	5.65B +40.2%
EPS	1.53 +41.6%
Shares Out	3.71B
PE Ratio	10.84
Forward PE	20.79
Dividend	0.41 (2.49%)
Ex-Dividend Date	Jan 5, 2026

Volume	1,243,200
Average Volume	10,215,902
Open	16.58
Previous Close	16.58
Day's Range	16.53 - 16.64
52-Week Range	16.23 - 19.68
Beta	0.33
RSI	33.48
Earnings Date	Mar 30, 2026

About SHA:601607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 50,120
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 601607

Financial Performance

In 2024, SHA:601607's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.